Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05022927
What this trial is testing

A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Chugai Pharmaceutical 179
Not applicableLooking for participantsNCT06876753
What this trial is testing

Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 300
Not applicableStudy completedNCT06544005
What this trial is testing

Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer Metastasis

Who this might be right for
Hepatocellular Carcinoma
Ain Shams University 198
Not applicableUnknownNCT04688606
What this trial is testing

Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer

Who this might be right for
Circulating Tumor Cell
Zhongnan Hospital 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04563338
What this trial is testing

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung Cancer MetastaticLiver Metastases
University Health Network, Toronto 36
Not applicableWithdrawnNCT03636607
What this trial is testing

Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma

Who this might be right for
Positron-Emission TomographyCarcinoma, Hepatocellular
Fifth Affiliated Hospital, Sun Yat-Sen University
Testing effectiveness (Phase 2)Study completedNCT00004136
What this trial is testing

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center 59
Not applicableActive Not RecruitingNCT07444905
What this trial is testing

Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaMachine LearningEvaluation
Tongji Hospital 1,523
Not applicableLooking for participantsNCT07476651
What this trial is testing

Scout Dose of Resin Microspheres

Who this might be right for
RadioembolizationHepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (ICC)+1 more
Seoul National University Hospital 30
Very early researchLooking for participantsNCT07242417
What this trial is testing

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

Who this might be right for
Solid CancerGPC3 Positive Hepatocellular Carcinoma
Beijing GoBroad Hospital 30
Early research (Phase 1)Study completedNCT04313868
What this trial is testing

GEN2 Directed Cancer Immunotherapy Trial

Who this might be right for
Hepatocellular CarcinomaMetastatic Cancer
GenVivo, Inc. 61
Not applicableStudy completedNCT06102278
What this trial is testing

ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

Who this might be right for
Peritoneal Metastasis
Chen Xiaoping 522
Early research (Phase 1)Study completedNCT01337050
What this trial is testing

Asian Phase I Study Of PF-03446962

Who this might be right for
Neoplasms
Pfizer 36
Not applicableActive Not RecruitingNCT07669597
What this trial is testing

Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag

Who this might be right for
Locally Advanced or Metastatic Hepatoceullar Carcinoma
Sohag Oncology Center 50
Not applicableStudy completedNCT04970212
What this trial is testing

Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures

Who this might be right for
Carcinoma, HepatocellularMetastatic Liver Cancer
Techsomed Medical Technologies LTD 65
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Early research (Phase 1)Active Not RecruitingNCT03028311
What this trial is testing

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Who this might be right for
Metastatic Liver CarcinomaStage IV Liver CancerStage IVA Liver Cancer+1 more
M.D. Anderson Cancer Center 12
Not applicableActive Not RecruitingNCT04573881
What this trial is testing

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

Who this might be right for
Liver NeoplasmsHepatocellular CarcinomaLiver Metastases
HistoSonics, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00519688
What this trial is testing

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 44
Testing effectiveness (Phase 2)Study completedNCT04511455
What this trial is testing

Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment

Who this might be right for
Hepatocellular Carcinoma Non-resectableMetastatic Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 22
Next Page